BiotechTV’s Post

AI-designed selective mRNAs and targeted LNPs are revolutionizing cancer and autoimmune disease treatment. By enabling in situ engineering, these therapies target diseased cells with unmatched precision and effectiveness. The future of medicine is here! #CancerTreatment #AutoimmuneDisease #AI #mRNA #LNP

In the News: Streamline Manufacturing of Antibody-Based Therapeutics 🌟 Discover the latest in the world of FDI and Business! Check out this insightful piece. 💡🌍 The global market for antibody therapeutics is rising rapidly as newer modalities such as are entering clinical studies in record numbers. 🔗 [Learn more: https://lnkd.in/dEEqW7TA] Join as a Partner and Professional: FDI Alliance: www.fdialliance.com Valqus Accounting and Business: www.valqus.com #FDI #Invest #Trade #TradeandInvest #InvestmentPromotion #Markets #Business #Accounting

AGC Biologics explains how they incorporated rapid cycle Protein A membrane chromatography to boost productivity in a single-use GMP manufacturing scale antibody production suite. This paper provides the details. Exciting new technology improving speed, lowering costs, and increasing productivity! Well done!   https://lnkd.in/gViGAYZN #antibodies #proteinpurification

Exciting work from AGC Biologics demonstrating an intensified and single-use downstream operation for antibody therapies using Protein A membrane chromatography showing: -     10x higher productivity over resin for Protein A capture -     An analysis of equivalency to resin #antibodies #proteinpurification

In the News: Streamline Manufacturing of Antibody-Based Therapeutics 🌟 Discover the latest in the world of FDI and Business! Check out this insightful piece. 💡🌍 The global market for antibody therapeutics is rising rapidly as newer modalities such as are entering clinical studies in record numbers. 🔗 [Learn more: https://lnkd.in/dEEqW7TA] Join as a Partner and Professional: FDI Alliance: www.fdialliance.com Valqus Accounting and Business: www.valqus.com #FDI #Invest #Trade #TradeandInvest #InvestmentPromotion #Markets #Business #Accounting

Well it wasn’t very long before I am headin’ back to America’s FINEST CITY! PepTalk 2024 - here is what my goals are: 1️⃣ I’m looking forward to diving into the world of Bispecifics purification - also known as “hey, which one of you is the heterodimer?” Attend our luncheon seminar on Tue to learn more! 2️⃣ Set up our booth in <30 min and save time to visit as many sessions as possible! Some topics I’m personally excited to learn more about is: 🛠️ TOOLS for Analysis of force degraded Abs (1:35 PM Tue) 🔍 Proteomic/transcriptomic analysis of Ab-producing CELL LINES (5:15 PM Tue) ⚖️ Which Ab FORMATS are most Developable? (2:00 PM Wed) 3️⃣ “Drink it in, it always goes down smooth” - one of my favorite quotes from Anchorman 🎤. In other words, enjoy my time in San Diego. Unlike Bay Area, I do expect better/warmer weather! Who’s attending and who wants to catch up? #peptalk #antibodydiscovery #biotech #sandiego #peptalk2024

80% of drug targets remain beyond the reach of traditional drug modalities. ❌ Small molecules cannot bind their large featureless interfaces. ❌ Biologics are not able to reach them inside the cell. ✅ Next-generation macrocycles CAN DO BOTH. Learn how Menten AI uses generative AI to design next-generation macrocycles: https://www.menten.ai #hitdiscovery #drugdiscovery #drugdevelopment #peptides #peptidetherapy #cyclicpeptides #macrocycles #therapeutics #artificialintelligence #ai #generativeai #therapeutics

Drug-Linker manufacturing and ADC conjugation facilities require specific regulatory knowledge and an engrained safety culture. They also bring their own unique design, construction and operational challenges. My presentation at INTERPHEX Global has generated some really great conversations about the future of this modality and how we plan to push towards that future. Let's keep the discussion going - what are your biggest challenges when designing and operating these complex facilities? #CRB #ADC #AntibodyDrugConjugate

Join Jérémy Peyrol from MilliporeSigma in this upcoming webinar where he presents a unique opportunity to delve into the convergence of cutting-edge technology and bioprocessing. Here, Raman spectroscopy stands out as a game-changer, unveiling the intricacies of glycosylation patterns in real time—an essential element in the manufacturing of monoclonal antibodies. The use case highlighted in this webinar illustrates a methodology for building robust and proven glycan models, enabling real-time monitoring of the glycosylation profile. It opens new doors for tailoring and optimizing glycosylation patterns throughout the monoclonal antibody manufacturing process. Key Learning Objectives of this webinar: 👉 How Raman spectroscopy will enhance your process monitoring capacities integrating high end CQAs (glycans) 👉 How to assess model quality: accuracy and robustness 👉 How to perform Raman measurement regardless of lab light environment 📅 Date - 2nd July ⌚ Time - 3pm London / 10am New York Click here to register for free - https://lnkd.in/dY52RDvn #pharma #bioprocessing #ramantechnology #biotech #glycosylation

With complexity of antibody products on the rise, so are manufacturing costs. That’s just another reason why we are backing VHH antibodies. As single protein domains, complexity is kept to a minimum. This makes is even easier to leverage low-cost manufacturing technologies such as yeast-based systems. In this clip, IP Director Chris Finnis from Phenotypeca shares why VHHs were a great choice for developing their QTL technology, optimising biologics manufacture from baker’s yeast. For the full story behind our Innovate UK funded grant project, read the case study here: https://lnkd.in/eXtfnsSa #VHHantibodies #Biotechnology #Nanobodies #Partnership #antibodies #therapeutics #TheVHHCompany #SME #antibodyproduction #proteinexpression #BIO2024